Cartiac: Comparative Cardiovascular Safety of CAR T Products for Non-Hodgkin’s Lymphoma – a Propensity Score–Matched International Multicenter Study

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Mohammad Alhomoud, Ali Abed Al Wahad, Samantha Brown, Uri Greenbaum, Tobias Tix, James Di Palma-Grisi, Elan Baskir, Sarah Samorodnitsky, Parastoo Bahrami Dahi, Alessandra M. E. Holzem, Linus Kruk, Marion S. Subklewe
+27 more Sandeep Raj, Marina Gomez-Llobell, Sigrun Einarsdottir, Sapir Israeli, Silvia Escribano-Serrat, Roi Westreich, Noa Golan Accav, Ori Ben Valid, Ronit Marcus, Avichai Shimoni, Arnon Nagler, Manhal Habib, Jabour Halloun, Richard Jirui Lin, Michael Scordo, Gunjan L. Shah, Craig Steven Sauter, Ofrat Beyar‐Katz, Gilles Salles, Jae H Park, M. Lia Palomba, Miguel‐Angel Perales, Roni Shouval, Abraham Avigdor, Andrew Ip, Kai Rejeski, Jennifer Liu
DOI: 10.1016/j.jtct.2025.12.030
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Chemotherapy-induced cardiotoxicity and mitigation Cardiac tumors and thrombi

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S14–S15
Publication date
1 February 2026
Language
EN